Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

NovoSeven

- PMLiVE

Science doesn’t sell

Healthcare communications aren’t lacking in clinical data - what they need is a dose of advertising ideals

- PMLiVE

Concentric Health Experience eyes European expansion

Appoints Peter Carr and Arron O’Hare as part of regional expansion plans

- PMLiVE

Harnessing commercial innovation

Novo Nordisk’s Christian Kanstrup on meeting challenges head-on and preparing for an era of launches

- PMLiVE

Why don’t big pharma brands win creative awards?

There’s a striking lack of correlation between commercial and creative success

Novo Nordisk adds to board of directors

Brian Daniels elected to join the board

- PMLiVE

Death by Numbers

The iconic ads that could have been

- PMLiVE

The tribe has spoken

Who gets to decide which profit margin is acceptable?

- PMLiVE

Lantus sales decline as competition heats up at Sanofi

Brand affected by biosimilars, growth of other new drugs and pricing pressure

- PMLiVE

Tresiba safer than insulin glargine, says Novo Nordisk

Trial compares its basal insulin with Sanofi's Lantus

- PMLiVE

Novo Nordisk files improved haemophilia B therapy in EU

Nonacog beta pegol is due to be submitted to US regulators in the next few months

Case study: Opportunity Assessment for a Rare Disease Product in Emerging Markets

Using in-depth-interviews to determine how to maximise the commercial opportunities in different emerging markets

Research Partnership

Sanofi reception

Sanofi uses priority review voucher for diabetes combo

LixiLan in race with Xultophy in bid to hit US market first

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links